This company has been marked as potentially delisted and may not be actively trading. Clearside Biomedical (CLSD) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Get the Latest News and Ratings for CLSD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Clearside Biomedical and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLSD Analyst Ratings Over TimeTypeCurrent Forecast5/21/25 to 5/21/261 Month Ago4/21/25 to 4/21/263 Months Ago2/20/25 to 2/20/261 Year Ago5/21/24 to 5/21/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)1 Buy rating(s)1 Buy rating(s)5 Buy rating(s)Hold5 Hold rating(s)5 Hold rating(s)5 Hold rating(s)0 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)0 Sell rating(s)Consensus Price Target$50.00$56.25$63.00$75.00Forecasted Upside12,095.12% Upside13,619.51% Upside15,265.85% Upside492.35% UpsideConsensus RatingReduceHoldHoldBuy CLSD Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CLSD Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Clearside Biomedical Stock vs. The CompetitionTypeClearside BiomedicalMedical CompaniesBroader MarketConsensus Rating Score 1.83 2.30 2.52Consensus RatingReduceHoldModerate BuyPredicted Upside12,095.12% Upside1,724.50% Upside16.20% UpsideNews Sentiment RatingNeutral NewsSee Recent CLSD NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails11/18/2025 Needham & Company LLC4 of 5 starsSerge Belanger4 of 5 starsReiterated RatingHold11/1/2025 Weiss RatingsNot Rated Initiated CoverageSell (E+)7/18/2025 HC Wainwright4 of 5 starsYi Chen2 of 5 starsDowngradeBuy ➝ Neutral$75.00+730.84%7/18/2025 Chardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDaniil GataulinSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Neutral7/18/2025 Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeBuy ➝ Hold$30.00+232.34%7/17/2025 JonesTradingSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeStrong-Buy ➝ Hold5/16/2025 Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJonathan WollebenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingMarket Outperform$75.00 ➝ $75.00+466.89%6/25/2024 OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Initiated CoverageOutperform$75.00+362.96%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 12:30 AM ET. CLSD Forecast - Frequently Asked Questions What is Clearside Biomedical's forecast for 2026? According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Clearside Biomedical is $50.00, with a high forecast of $75.00 and a low forecast of $30.00. Should I buy or sell Clearside Biomedical stock right now? 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clearside Biomedical in the last twelve months. There is currently 1 sell rating and 5 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CLSD shares. Does Clearside Biomedical's stock price have much upside? According to analysts, Clearside Biomedical's stock has a predicted upside of 12,095.12% based on their 12-month stock forecasts. Do Wall Street analysts like Clearside Biomedical more than its competitors? Analysts like Clearside Biomedical less than other "medical" companies. The consensus rating for Clearside Biomedical is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how CLSD compares to other companies. Stock Forecasts and Research Tools Related Companies Addex Therapeutics Stock Forecast Nuvilex Stock Forecast Creative Medical Technology Stock Forecast Bullfrog AI Stock Forecast Portage Biotech Stock Forecast NuCana Stock Forecast Brainstorm Cell Therapeutics Stock Forecast Biodexa Pharmaceuticals Stock Forecast Lunai Bioworks Stock Forecast BioAtla Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Clearside Biomedical RecommendationsNeedham & Company LLCWeiss RatingsWall Street ZenHC WainwrightStifel NicolausChardan CapitalJonesTrading This page (NASDAQ:CLSD) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearside Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
